Scynexis Inc (SCYX) SEC Filing 8-K Material Event for the period ending Friday, February 4, 2022

Scynexis Inc

CIK: 1178253 Ticker: SCYX

View differences made from one to another to evaluate Scynexis Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Scynexis Inc.


Assess how Scynexis Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Scynexis Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors



Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Material Contracts, Statements, Certifications & more

Scynexis Inc provided additional information to their SEC Filing as exhibits

Ticker: SCYX
CIK: 1178253
Form Type: 8-K Corporate News
Accession Number: 0001564590-22-004229
Submitted to the SEC: Tue Feb 08 2022 4:01:21 PM EST
Accepted by the SEC: Tue Feb 08 2022
Period: Friday, February 4, 2022
Industry: Pharmaceutical Preparations
  1. Event for Officers
  2. Financial Exhibit

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: